Podcasts about healthtech

In this powerful episode of Mindset Mastery Moments, Dr. Alisa sits down with Guy Bar, Founder and CEO of ARGOX, to unpack a journey defined by discipline, innovation, and bold execution.Guy shares how his early experience serving in the Israeli Defense Forces shaped the mindset, resilience, and leadership philosophy that later fueled his transition into entrepreneurship. What began as a solution to a personal training challenge evolved into Hygear Fit and eventually ARGOX—two brands at the forefront of AI-powered fitness and connected health technology.Together, they explore:How military discipline translates into entrepreneurial gritWhy AI-driven fitness is not a trend, but the future of personalized trainingThe real challenges of scaling a hardware and health-tech startup globallyLessons learned from supply chains, product-market fit, and innovation under pressureThe mindset required to build meaningful companies in uncertain environmentsThis episode is a masterclass in vision, adaptability, and execution—especially for founders, innovators, and leaders navigating high-stakes growth while staying anchored in purpose.If you're interested in the intersection of mindset, technology, and the future of human performance, this conversation delivers insight without fluff and strategy without shortcuts.

Welcome to Pulse: Year in Review, where Louise and George unpack the big stories from Pulse+IT's 2025 Year in Review series.Segment 1: AI goes mainstreamSegment 2: Modernisation, Standards, and the Path to IntegrationSegment 3: Risk, Governance & its Relationship to InnovationResources:Pulse+IT 2025 Year in Review: Australian digital health LinkPulse+IT 2025 Year in Review: New Zealand digital health LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Welcome to the latest episode of L.I.F.T.S, your bite‑sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal sit down with Mohit Kumar, Co‑Founder and CEO of Ultrahuman, to explore the explosive rise of smart rings and the future of wearable health technology. Topics covered include: Mohit's unconventional founder journey and early days in metabolic health. Why smart rings are outperforming other wearables in growth. Ultrahuman's approach to sleep, metabolism, and biomarkers. The high‑stakes patent battle with Oura and the U.S. import ban. What resilience really looks like for founders. The future of AI, battery life, and ring‑based health tracking. Why sleep is becoming the most important performance metric.

Healthtech Marketing Predictions for 2026 On this episode host Adam Turinas closes out the year by looking forward. In this episode, you'll hear a range of voices from across healthtech marketing, growth, PR, podcasting, and the Health Launchpad team as they share what's already starting to shift beneath the surface—and what that means for the year ahead. Some of the predictions may feel inevitable. Others might make you a little uncomfortable. That's usually a good sign. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

SomX's Belle Taylor and Harry Salt dive into this week's healthtech news with Prof. Susan Shelmerdine, Associate Professor of Radiology / AI at UCL Great Ormond St Hospital.

What happens when a class clown from Monaghan builds one of the most quietly impactful healthtech companies in Europe - and then takes on the U.S. healthcare system? In this year-end episode of The Shot of Digital Health Therapy, we sat down with Neill Dunwoody

Episode 70 - Dr Mark Hudson-Peacock is a Consultant Dermatologist and founder and CEO of Mantara Health Ltd, responsible for launching the first commercially available Pharmacogenomics test in the UK. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

In this episode of Medsider Radio, we sat down Dr. Adam Kadlec, practicing urologist and co-founder of Rivermark Medical.Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH).Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experiences that ultimately revealed how early true device development begins and why physicians rarely get the chance to influence innovation upstream. Partnering with medtech operator Andy Doraiswamy, Adam transitioned from clinician to CEO and is now leading Rivermark through its pivotal trial.In this interview, Adam shares why workflow integration is one of the most overlooked drivers of adoption, how physician-innovators can build the right decision-making infrastructure, and why understanding who actually enrolls patients at clinical sites can make or break a trial. He also touches on the mindset required to stay resilient through the ups and downs of building a medtech startup.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Adam Kadlec.

Join host Dr. Eve Cunningham in conversation with Dr. Shayan Vyas, pediatric intensivist, health-tech leader and Chief Medical Officer at Quadrivia AI, as they unpack the most meaningful shifts in healthcare in 2025 and what those changes signal for the year ahead. From early telemedicine to AI-enabled clinical support, Dr. Vyas has spent more than a decade building technology that actually works for clinicians, making him one of the most experienced physician innovators in the field.Their conversation dives into:How ambient AI finally moved from pilots to enterprise adoptionWhy clinicians' trust in AI is accelerating faster than expectedThe growing imbalance between patient demand and clinical workforce supplyHow technology can reduce friction, extend reach, and improve access to carePredictions for 2026 – from reimbursement instability to the next wave of AI in clinical workflowsPractical advice for clinicians entering digital health, from “falling in love with the problem” to protecting the art of medicineDr. Vyas is not compensated for this podcast.For more information on Cadence, visit https://www.cadence.care/

Fluent Fiction - Mandarin Chinese: Startup Sparks: A Christmas Eve Pitch That Changed Everything Find the full episode transcript, vocabulary words, and more:fluentfiction.com/zh/episode/2025-12-16-23-34-02-zh Story Transcript:Zh: 在一个寒冷的冬日，城市的天空灰蒙蒙的，气温降得很低。En: On a cold winter day, the city's sky was gray and the temperature dropped significantly.Zh: 然而，在这座现代的创业孵化器内，却充满了热情和希望。En: However, inside this modern incubator, there was an atmosphere of enthusiasm and hope.Zh: 圣诞节的装饰让整个房间显得更为温馨，绿意点缀着科技的冷色调。En: The Christmas decorations made the entire room feel cozier, with greenery softening the cool tones of technology.Zh: 梅和陈坐在他们的办公桌旁，眉头紧锁。En: Mei and Chen sat by their desks, their brows furrowed.Zh: 梅是一位聪明而乐观的技术开发者，她对创新充满了热情，但内心深处害怕失败。En: Mei was a smart and optimistic tech developer, passionate about innovation but deeply afraid of failure.Zh: 陈是一个注重策略的思考者，实际而沉稳，但他对他们的创业计划能否成功心存疑虑。En: Chen was a strategic thinker, practical and steady, yet he doubted whether their startup plan would succeed.Zh: 他们的目标很明确：在新年到来之前，获得足够的资金支持，以维持他们的健康科技初创公司的运营。En: Their goal was clear: to secure enough funding before the New Year to maintain the operation of their health tech startup.Zh: 然而，形势不容乐观。En: However, the situation was not optimistic.Zh: 市场竞争激烈，投资者对他们的产品能否大规模推广持怀疑态度。En: The market competition was fierce, and investors were skeptical about the mass adoption of their product.Zh: 此时，节日的临近使得会议和决策的速度放缓，这给他们的计划增加了不小的难度。En: With the holiday season approaching, the speed of meetings and decisions slowed down, adding significant difficulty to their plans.Zh: 梅大胆地提出，要在平安夜亲自向一位潜在的重要投资者展示他们的原型机，用实力说话。En: Mei boldly proposed showcasing their prototype to a potential major investor on Christmas Eve, letting their work speak for itself.Zh: 陈非常支持她的决定，但同时他感到了巨大的压力，担心如果他们失败了，后果将会很严重。En: Chen fully supported her decision but simultaneously felt immense pressure, fearing the serious consequences if they failed.Zh: 到了平安夜，他们站在一排白板前，上面画满了各种图表。En: On Christmas Eve, they stood in front of a row of whiteboards filled with various charts.Zh: 在喧闹的创业孵化器中，梅和陈准备展示他们的心血。En: In the bustling incubator, Mei and Chen were ready to present their hard work.Zh: 初次展示时，他们的原型机忽然出现了问题，这让投资者的兴趣明显减弱。En: During the initial presentation, their prototype suddenly encountered problems, noticeably reducing the investor's interest.Zh: 梅用她出色的解决问题能力，迅速开始现场排查故障。En: Mei, with her excellent problem-solving skills, quickly began troubleshooting the issue on the spot.Zh: 与此同时，陈用充满激情的话语解释他们的愿景和产品的潜在影响力。En: Meanwhile, Chen passionately explained their vision and the potential impact of their product.Zh: 他那真诚和坚定的声音再次激起了投资者的兴趣。En: His sincere and firm voice reawakened the investor's interest.Zh: 经过一番努力，问题终于被解决，原型机顺利运行。En: After much effort, the issue was finally resolved, and the prototype ran smoothly.Zh: 投资者不仅被他们的聪明才智打动，也被他们的毅力与理想所感动。En: The investor was not only impressed by their ingenuity but also moved by their perseverance and ideals.Zh: 最终，投资者决定支持这对充满激情和潜力的创业者。En: In the end, the investor decided to support this passionate and promising pair of entrepreneurs.Zh: 他承诺提供资金，帮助他们实现革命性的健康科技梦想。En: He promised to provide funding to help them realize their revolutionary health tech dreams.Zh: 圣诞节的灯火亮起，喜悦的火花在梅和陈的心中闪烁。En: As the Christmas lights lit up, sparks of joy flickered in Mei and Chen's hearts.Zh: 梅对自己的能力有了更多的信心，而陈也学会了相信他们的共同目标，并相信他们能够克服任何障碍。En: Mei gained more confidence in her abilities, and Chen learned to trust their shared goal and believed they could overcome any obstacle.Zh: 冰雪虽寒，但梦想温暖，他们在这条艰难而美好的路上，坚定地走了下去。En: Though the ice and snow were cold, dreams were warm, and they resolutely continued on this challenging yet beautiful path. Vocabulary Words:incubator: 孵化器enthusiasm: 热情cozy: 温馨furrowed: 紧锁optimistic: 乐观innovation: 创新strategic: 策略的succeed: 成功fierce: 激烈skeptical: 怀疑的adoption: 推广troubleshooting: 排查故障impact: 影响力sincere: 真诚ingenuity: 聪明才智perseverance: 毅力entrepreneurs: 创业者realize: 实现revolutionary: 革命性的overcome: 克服obstacle: 障碍prototype: 原型机firm: 坚定resolve: 解决investor: 投资者charts: 图表operation: 运营doubt: 心存疑虑significantly: 显著pressure: 压力

AI Quick-Take: What's All The Fuss About Gemini? On this episode host Adam Turinas discusses the buzz around Gemini 3, Google's LLM. He digs into Google's big announcement and tries to get past the hype to what it really means for healthtech marketers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

SomX's Jessica Somauroo interviews Healthtech VC Andrew Elder.

Send us a textFederally Qualified Health Centers (FQHCs) care for more than 30 million Americans, yet many people have never heard of them or understand how they stay afloat. A major piece of their financial survival is the 340B drug pricing program, which has quietly become one of the most important funding mechanisms in the safety net and it is under growing pressure.Scott Seidelmann, CEO of Nuvem, joins CareTalk hosts David E. Williams and John Driscoll to discuss how FQHCs serve underserved communities, why 340B has become essential to their operations, and what policy changes could make or break their ability to deliver care.

In this special HLTH bonus episode of Tech It to the Limit, hosts Sarah Harper and Elliott Wilson battle post-conference fatigue and full-blown health FOMO by bringing the conference floor straight to your earbuds. While Sarah recovers from a “very real case of health FOMO,” Elliott reports from the trenches after surviving days of buzzwords, badge scanners, and $9 lattes. To shake up the usual format, they press play on two standout booth interviews from HLTH.First, Elliott sits down with Dr. Lynne Nowak of Surescripts for a deep dive into seamless prescribing, touchless prior authorization, interoperability, and price transparency. Dr. Lynne breaks down how automation is shrinking prior auth from a multi-day nightmare into a near-instant, 30-second reality, reducing burnout for clinicians and removing friction for patients who just want their meds on time and at a price they can afford.Then, the episode shifts into venture-building mode with returning guest John Beadle of Aegis Ventures. John unpacks how his consortium model is helping health systems move from “innovation theater” to real innovation delivery by building and scaling AI companies faster than the market average. From ambient AI becoming table stakes to the rise of patient-facing agents, he offers a clear view of where healthcare innovation is headed next.In this episode:[00:00] Introduction[01:16] Health conference recap setup[07:13] Interview Dr. lynne Nowak automation and burnout[10:25] Touchless prior authorization explained[12:59] Interoperability and data exchange[18:11] Trust and data governance[19:55] Future of data science at Surescripts[21:12] Interview wrap up Dr. lynne[24:42] Interview John Beadle AI startups and health systems[26:02] Startup success metrics and examples[28:11] Clinician experience and ambient AI[32:19] Advice for health conference attendees[33:07] Sponsor segment HIPAA compliance tool[34:22] Episode wrap up and teaser for part two[35:40] Healthtech haiku and sign-offResources:Tech It To The Limit PodcastWebsite Apple PodcastDr. Lynne NowakLinkedIn -https://www.linkedin.com/in/lynnee-nowak-md-62054583/Surescripts - https://surescripts.com/John BeadleLinkedIn - https://www.linkedin.com/in/johnpbeadle/Aegis Ventures - https://aegisventures.com/Sarah HarperLinkedIn -https://www.linkedin.com/in/sarahbethharperElliott WilsonLinkedIn - https://www.linkedin.com/in/matthewelliottwilson

In this session Sofya shares her journey building a pet-tech startup that blends machine learning sensor data and canine behavior analytics. She walks through her path from early programming explorations to launching a health monitoring device designed around anomaly detection and long-term behavioral baselines.TIMECODES: 00:00 Sofya's pet tech startup with machine learning sensor data and behavior pattern analytics10:00 Journey from programming hobby to full time software development career17:20 Career growth after skipping university and building practical experience24:07 Puppy adoption story and family influence on pet focused innovation32:16 Dog health monitoring framed as anomaly detection in real world machine learning37:05 Collecting canine data with emphasis on sleep patterns and cycle tracking43:35 Establishing a dogs normal baseline through long term data observation49:34 Startup funding through personal savings and early stage bootstrapping55:28 Finding cofounders and collaborators through meetups and coworking communities59:48 Closing insights on Sofya's educational path and early device prototypesConnect with Sofya- Website - https://www.fit-tails.com/ - Linkedin - https://www.linkedin.com/in/sofya-yulpatova/Connect with DataTalks.Club:- Join the community - https://datatalks.club/slack.html- Subscribe to our Google calendar to have all our events in your calendar - https://calendar.google.com/calendar/r?cid=ZjhxaWRqbnEwamhzY3A4ODA5azFlZ2hzNjBAZ3JvdXAuY2FsZW5kYXIuZ29vZ2xlLmNvbQ- Check other upcoming events - https://lu.ma/dtc-events- GitHub: https://github.com/DataTalksClub- LinkedIn - https://www.linkedin.com/company/datatalks-club/ - Twitter - https://twitter.com/DataTalksClub - Website - https://datatalks.club/

Guest: Derek Baird, CEO & Co-founder, Switchboard HealthResources:Switchboard Health: https://switchboardhealth.com/Conduce Health: https://www.conducehealth.com/Connect with Derek: https://www.linkedin.com/in/debaird/Connect with Nick: https://www.linkedin.com/in/nick-crabbs-5674a233/ Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

HSBC Innovations is the global bank's financing arm for American and European startups, especially in the healthcare and life sciences industries. The bank's semi-annual Venture Healthcare Reports document trends in the investment market.Key Tech's Andy Rogers welcomes the report's author, HSBC Innovation Managing Director Jon Norris in Episode 43 of the MedTech Speed to Data podcast.Need to know·       Four core market segments — HSBC Innovation's Venture Healthcare Reports cover investments and exits in Biopharma, Dx/Tools, Med Device, and Healthtech.·       Sourcing investment data — Norris enriches Pitchbook data with additional structure and analyses, making the report more relevant to these market segments.·       Sourcing exit data — Norris supplements media and industry publications with market research and conversations with industry leaders.·       An investment data tapestry — The reports provide “an honest picture of what's going on in the market” so investors and innovators alike “can make targeted smart decisions.”The nitty-grittyAndy and Norris discuss the investment market's recent history before exploring drivers of today's investment headwinds.“2021 was a record-setting year,” Norris recalls. “Every record that could be set for deals and dollars was set across all the sectors.” Things changed in 2022 as new BioTech IPOs struggled, prompting investment reprioritizations.“VCs had done all these… frothy valuations,” Norris says. “They had to go back and look at their own portfolios and say, does this company have enough capital? How do you want to put money to work?”Investments rebounded in 2024, but not the number of deals. Investors poured money into their existing portfolios to boost their exit chances, resulting in today's nine-figure megadeals.“Basically, they're smooshing two rounds together and extending the investors coming in to support that round,” Norris says.Headwinds stiffened in 2025 as tariffs, a more litigious competitive space, and other factors amplified business uncertainty.Norris attributes this progression to the psychology of venture capital. “When you think about what makes these folks tick,” Norris explains, “they want to continue to raise new venture funds because they get paid management fees. But in order to raise their new venture funds, they have to show their investors that they've actually gotten returns.”That means reaching an acquisition or IPO. “They're very focused on getting to exit right now. That's why they're so focused on their existing portfolio. And because of that, they haven't been doing as many new investments.”New investments still happen, of course, but the criteria have changed. “While the dollars are actually up in some of these sectors, especially Med Device,” Norris says, “you're seeing that being put to work on later-stage deals because they'd rather get a shorter time to exit.”Data that made the difference:Norris' insights from the HSBC Venture Healthcare Report let him advise startups fighting today's investment headwinds.Adopt a megaround mentality. “Series B has been extremely difficult,” Norris says. “[Raising] sub two million, that's one thing. But if you're looking to raise five million, it's almost better to raise twelve.”Find investors outside the mainstream. “Traditional venture investors don't want to write small checks.” Norris sees angel groups, innovation centers, and other small investors funding these early rounds.Explore acquisition exits, but be careful. “On the device side, most of the corporates have been pretty darn active,” Norris says. However, some litigate to block emerging competition, especially in the Dx/Tools sector. Norris' recommends researching potential acquirers before taking meetings.Download the HSBC Venture Healthcare Report for Norris' complete analysis, and watch the video below for insights into the Medical Device and Dx/Tools sectors, AI's role in MedTech, and more.

Welcome to Pulse: Hot Topics, where Louise and George unpack the big shifts shaping healthcare right now - from billion-dollar hype to human-level trust.Are AI Scribes The Billion-Dollar Burnout Band-Aid?Doctors adore them, investors can't stop funding them - We dig into the paradox of technology that makes clinicians happy but might not be improving productivity—and why transparency is becoming urgent as these tools expand into agentic workflows.Chatbots in Therapy: When AI Joins the SessionFrom therapists secretly using ChatGPT mid-session, to patients uploading their medical records for advice, and one founder shutting down his AI therapy app over safety fears — can AI-mediated care ever truly be therapeutic?New Zealand's Digital Déjà VuAfter a tough 2024, New Zealand's back with a 10-year digital health plan, a new Centre for Modernisation, and a promise of one innovation a month. But with no funding announcement and an election looming, is this genuine commitment or just another round of hopeful planning? Tender watch is on.MIT's Top 10 Breakthrough TechnologiesMIT Technology Review's annual list has brain–computer interfaces voted readers' #11 pick. Are BCIs about to finally enter their translation era? And would George drill a hole in his head for the tech?The BMJ vs. TikTok MedicineWhat happens when money, marketing, medicine, and misinformation collide? Raffael Heiss can tell you as he's mapped it. Spoiler alert: it's not god. Tina Purnat argues we can't regulate this away—we need to recognise the information environment as a determinant of health.Resources:AI Scribes paper, NEJM AI LinkNZ DH Strategy, Pulse+IT Story LinkMIT Technology Review's Breakthrough Tech List LinkPublic health challenges of ‘medical influencers' BMJ LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of Medsider Radio, we sat down with Andrew Holman, MD, CEO of Inmedix. Inmedix is commercializing CloudHRV, an FDA-cleared diagnostic that quantifies biological stress with clinical precision to guide treatment decisions in autoimmune disease and beyond.Andrew is a practicing rheumatologist in Seattle with 25 years of clinical and research experience. His discoveries linking autonomic dysfunction to autoimmune disease outcomes led to a $10 million patent sale to Boehringer Ingelheim. After a decade in retirement, he returned to found Inmedix and pioneer the field of immuno-autonomics — preparing the market for his technology years before launch.In this interview, Andrew shares how to build a category before commercializing a product, why clinical evidence creates competitive moats that money can't replicate, and how to raise capital from angel investors by understanding what they actually care about.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Andrew Holman.

Send us a textLung cancer is often discovered too late, when treatments are expensive and survival rates are low. But what if routine chest x-rays could flag cancer early…long before symptoms appear? AI is transforming everyday imaging into a powerful early detection tool, reshaping screening economics and saving lives around the world. Prashant Warier, CEO and Founder of Qure.ai, joins CareTalk to discuss how AI enables earlier diagnosis, why chest x-rays are an untapped opportunity for detection, and what it takes to integrate AI into national health systems at scale.

Episode 69 - Dr Taz Aldawoud is a GP, NHS Innovation Accelerator Fellow and founding CEO of Doc Abode, a nationally recognised digital health company enabling the NHS to deliver faster, safer care closer to home. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Fewer, better things—that's my midlife mantra after the crazy-hard empty-nest downsizing. Smart, curated gifting feels right as we balance editing our lives and treating our loved ones as we head into 2026. London-based wellness editor Annie Goodman joins us fresh from trying "millions of face creams" to share her expertly vetted holiday guide. After her mother's health crisis sparked a holistic wellness transformation, Annie now curates for The Quality Edit. Discover results-driven skincare, health tech and LED masks, experiential gifts requiring zero wrap, and solo travel retreats. Plus, stocking stuffers galore! She's done the research—you get the perfect gift, beauties! FOLLOW A CERTAIN AGE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET INBOX INSPO: Sign up for our newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AGE BOLDLY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices

Building a Brand in Healthcare's Most Competitive AI Market On this episode host Adam Turinas discusses with friend and healthtech marketing leader, Lea Chatham, what it takes to create and build a strong brand. They discuss what it really takes to build a brand in the white-hot ambient AI/clinical scribe space. They start with the reality that large buying groups are overwhelmed with noise, and increasingly turn to a few trusted sources to quietly shortlist the top two or three vendors before they ever talk to sales. If you're not consistently showing up with credibility in those channels, you may never even make the long list, let alone the shortlist. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. What happens when AI becomes a valued third party in the clinical consultation between a clinician and the patient? George and Louise sit down with author and postdoctoral research fellow Dr David Fraile Navarro to discuss the British Medical Journal special on generative AI in the clinical encounter.Resources:Connect with David on LinkedIn LinkBMJ special on Generative AI and the Clinical Encounter LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of Medsider Radio, we sat down with Colby Holtshouse, President and CEO of May Health.May Health is developing a minimally invasive ovarian ablation therapy designed to restore ovulation in women with polycystic ovary syndrome (PCOS) and PCOS-related infertility.Before May Health, Colby served as Global Medtech Commercial Lead at Organon, overseeing the worldwide launch of the Jada System following Organon's acquisition of Alydia Health, where she held roles including COO, Interim CEO, and VP of Marketing. She has also held leadership positions at Pelvalon, AccessClosure, Medtronic, and Guidant.In this discussion, Colby shares why early clinical evidence should be built in focused layers rather than oversized, all-at-once trials. She explains how a small, deliberate early launch can reveal the workflow nuances and real-world expectations no study ever captures. And she outlines why founders should define the raise first — and how clarity, preparation, and a deep understanding of strategic partners can dramatically accelerate the fundraising process.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Colby Holtshouse.

Send us a textPhone lines are jammed. Staff are overwhelmed. Patients wait, hang up, or fall through the cracks entirely. Meanwhile, the pressure to improve access keeps climbing.In this Executive Feature, Chetan Reddy, Founder and CEO of Confido Health,  joins host, David E. Williams to discuss why patient access is breaking down, how AI voice agents can resolve routine calls instantly, and what it takes for practices to improve patient experience without adding staff.

Nicole Rodrigues is the CEO and Founder of NRPR Group, the Beverly Bills public relations and marketing machine serving game changing companies from entertainment to tech around the world. NRPR focuses on building relationships that build long-lasting ties between clients, the media and their audiences. From startups to Fortune 500 companies within consumer tech, FinTech, HealthTech, enterprise, mobile, digital entertainment, lifestyle, sports, and consumer products, NRPR prides itself on a high-touch, results-focused approach to boost their clients' bottom line.

Episode 68 - Lord (James) Bethell is an entrepreneur, ex-health minister and public-health advocate with 20 years' experience across government, media and industry, including The Sunday Times, US Senate and EU Commission. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

This Episode is sponsored by Figs - for professional, clean and functional scrubs, use FIGSUK for 15% off your first order

In the 69th episode of the Trade Show Talk podcast, host Danica Tormohlen interviewed Kinsey Fabrizio, president of the Consumer Technology Association (CTA) and producer of the Consumer Electronic Show (CES). They discuss what's new for CES 2026, which is expected to welcome more than 140,000 attendees from 150+ countries to Las Vegas in January.    The 2026 tech extravaganza will debut the CES Foundry focused on AI and quantum technologies, a show sector that will be held at Fontainebleau Las Vegas. Fabrizio shared insights from her recent trip to the UFI Global Congress in Hong Kong and outlined how CTA is leveraging AI to enhance attendee experiences through the event's mobile app.     Additionally, there's an advocacy update from Exhibitions & Conferences Alliance EVP Tommy Goodwin on the latest government and tariff developments affecting the trade show industry.    This episode is brought to my Trade Show News Network and is sponsored by Marriott.    Chapters   00:00 Introduction to Trade Show Talk  01:26 Meet Kinsey Fabrizio: Background and Achievements  02:47 Insights from the UFI Global Congress  05:06 Preview of CES 2026  06:25 Exciting New Features at CES 2026  08:18 The Role of Robotics and Health Tech at CES  12:42 Kinsey's Fabrizio's Journey and Leadership at CTA  22:54 Advocacy and AI in the Tech Industry  30:14 Personal Interests and Hobbies  31:10 Favorite Gadgets and Wishlist  35:27 Travel Tips and Hacks  39:06 Advocacy Update with Tommy Goodwin  39:33 Government Reopening and Tariff Discussions  46:05 Visa Fee and Industry Impact  50:17 Conclusion and Farewell    Guest bio: Kinsey Fabrizio Kinsey Fabrizio is president of the Consumer Technology Association (CTA)®, which represents more than 1,200 consumer technology companies and owns and produces CES® - the most influential tech event in the world. In this role, Fabrizio serves on CTA's Executive board and directs strategy and operations across all business units.  Since joining CTA in 2008, Fabrizio has driven transformation at both CTA and CES. As senior vice president, she oversaw CES conferences and show operations, led an expansion of CES products, and spearheaded a modernization of CTA's membership infrastructure and categories.  Earlier in her career, she drove strategic growth in emerging tech categories. A pioneer in the digital health space, Fabrizio created CTA's Health Division, launched a healthcare provider program for doctors at CES 2015, and debuted CES's first Continuing Medical Education (CME)-accredited conference in 2019. She also spearheaded the Video Division Board's 4K and 8K TV initiatives, founded the Content and Entertainment Council, and launched CTA's Disruptive Innovation Council in 2016 to engage companies with breakthrough technologies and services.  Fabrizio's leadership earned her recognition as one of Washingtonian's Most Powerful Women in 2025 and a Washingtonian Tech Titan in 2024 and 2025. She also received the 2023 Women in CT Legacy Award for her contributions to the consumer technology industry.  Fabrizio is a member of the George Mason University Costello College of Business Dean's Advisory Council and the Washington Economic Club. She holds a BA from George Mason University and an MBA from the University of Maryland Global Campus. She lives in Arlington, VA, with her husband and two children.  Guest bio: Tommy Goodwin Tommy Goodwin is Executive Vice President for the Exhibitions & Conferences Alliance (ECA), the advocacy association for the business events industry. In this role, he leads ECA's work on behalf of the interconnected ecosystem of exhibitors, event and meeting organizers, suppliers, venues, and destinations that comprise the global business events landscape. Prior to joining ECA, Tommy spent more than 20 years working for several globally recognized associations and corporations, including Oracle, AARP, and the Project Management Institute. Recognized by The Hill in its list of association "Top Lobbyists" every year since 2020, Tommy has also received several industry awards including: CEO Update/Association Trends: Leading Association Lobbyist (2023) American Society of Association Executives (ASAE): ASAE Fellow (2022) DCA Live: Association Innovation Leader (2022) Trade Show news Network: Industry Support Award (2022) MeetingsNet: Changemaker (2022) Host bio: Danica Tormohlen An award-winning journalist who has covered the trade show industry since 1994, Danica Tormohlen is VP of Group Content, Meetings, Sports, Travel for Informa Connect. In her role, she oversees content for Trade Show News Network, Corporate Event News, BizBash and Connect's portfolio of in-person events. These leading media brands publish websites, newsletters, social media channels, video, podcasts and online and in-person programming for the trade show, corporate event, association meeting, experiential marketing and exhibition industries. Tormohlen currently serves as president of the Women in Exhibitions Network North America chapter. She has been a speaker and moderator at major industry events, including the TSNN Awards, IMEX, IAEE, SISO, UFI, ESCA, DI and Large Show Roundtable — to name a few. Keywords: CES, Kinsey Fabrizio, Consumer Technology Association, AI, trade shows, event industry, technology trends, advocacy, digital health, robotics 

AI Quick Take - AEO vs SEO On this episode host Adam Turinas discusses if Answer Engine Optimization (AEO) is really just SEO with a fresh coat of paint, or are we looking at something fundamentally different? This question has been nagging at him for weeks, and in this AI Quick Take he tries to answer it. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Why We Still Can't Say ‘Vagina' at Work, and What It's Costing Women in Leadership. Ugh. I know. But there's hope:What if the biggest barrier to women's leadership isn't a lack of confidence, but the shame we're taught to carry about our own bodies?In this episode, Helena sits down with Kamola Mir, CEO and founder of Lidovex, a health-tech company building the world's first cervical (data) ecosystem. What begins as a conversation about fem-tech quickly expands into a deeper truth:You cannot build a world that values women if you still devalue the female body.From being laughed at on stage for saying the word “vagina,” to navigating investor meetings where a woman's worth is often assessed before her work isKamola breaks down the emotional, biological, and cultural realities women face when they lead inside male-designed systems.Together, we explore:Why de-stigmatizing women's bodies is a leadership issue, not a “women's topic”How shame shapes everything from our ambition to our burnout cyclesWhy female biology is not a weakness, but a strategic advantageThe hidden mental load female founders carry in every roomHow to stay authentic when the world rewards you for fitting inHow to build inner power even when the system feels riggedThis is an episode for every woman who has ever hustled through pain, silenced her intuition to appear “professional,” or tried to win inside a structure that was never built for her.If you're ready to unlearn the shame, reclaim your biology, and lead from a place of grounded power, this one is for you.Chapters:00:55 Intro: Why femtech isn't niche but a cultural revolution01:20 Moving past generations of research centered on white men02:16 The rise of women leading taboo-breaking innovation02:49 How women are finally steering investment and change03:37 Celebrating Kamola Mir, Founder/ CEO reshaping women's health with Lidavex: Building an ecosystem that returns ownership to women's bodies04:16 Kamola's Trauma: childbirth care built without women in mind06:00 Leaving patriarchal workplaces, listening to our inner voice and create the change we need in the world07:30 Women must fight for their bodies09:07 The moment intuition becomes survival in labor10:41 Why women need both intuition and data to lead well12:06 How shame still silences women's conversations about our bodies13:03 Reclaiming our anatomy and naming our truths without fear15:01 When saying “vagina” triggers giggles and how to speak up17:09 Patriarchy at work and why women don't fit the 9–5 mold19:37 Redefining productivity through the wisdom of female cycles21:08 Navigating sexualization while trying to lead authentically24:26 Three ways women can release shame and rise into leadership29:43 Building an immune system for disagreement and staying grounded under pressure31:53 The emotional cost of being ‘fuckable' in male-dominated spaces & how to deal with it33:07 Showing up empowered while navigating safety, power, and perception37:53 Knowing when to adapt, when to walk away, and when to stand your ground43:01 Why patriarchal hustle culture breaks women's bodies and how to reclaim balance Connect with Kamola on LinkedInDiscover, stay up to date, fund and support Lidovix' journey: Website and LinkedInUntil next time!! xx Connect with me:IG: https://www.instagram.com/whereboundariesdissolvepodcast?igsh=OGQ5ZDc2ODk2ZA%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@helena.arjuna?_t=8oSbtTilPSQ&_r=1LinkedIn: https://www.linkedin.com/in/helenasuter/ Youtube: https://youtube.com/@whereboundariesdissolvepodcast?si=g63NToOK45W1CiBI Support the show

Welcome to Pulse: Hot Topics, where Louise and George unpack the big shifts shaping healthcare right now. From Elon Musk's claim that Tesla's Optimus robot will soon have superhuman surgical skills, to scientists who are quietly making real breakthroughs with microscopic nanorobots, we separate spectacle from science. We look at the rise of at-home blood testing, unpack OpenAI's accelerating push into healthcare, and celebrate Rahma Health's double win at the Telstra Business Awards.Along the way, Louise and George explore what's hype, what's helpful, and what's actually happening behind the headlines — with their usual blend of sharp analysis, laughter, and a touch of existential dread about superhuman AI.Resources:Microscopic medical robots Nature articleAt home blood tests, Dr Bertalan Mesko Medical Futurist articleRhama Health innovation win Pulse+IT articleTGA Digital mental health survey LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Send us a textIn Episode 12 of the Digital and Dirt podcast, Ian sits down with Melissa Gordon-Ring, Global President of Health at IPG Mediabrands, to discuss the importance of trust and human connection within the evolving health landscape. Melissa shares her perspective on leadership and the future of health communications, offering insights from her professional and personal experiences.Podcast Breakdown00:00–05:51 Introduction, Personal Insights & Role of Family05:52–11:00 Career Journey & Passion for Healthcare11:01–18:59 Navigating Consumers & Understanding IPG Mediabrands19:00–23:24 Adapting to Change & Building Trust23:25–29:06 Simplifying Healthcare Communication & Innovation29:07–32:08 Embracing Change in Media & Health Tech32:09–End The Future of Health Tech & Empowering Teams

Building Resilience in Healthcare Marketing On this episode host Adam Turinas discusses, with Mark Erwich, Health Launchpad Chief Strategy Officer, the mounting pressures on hospitals and IDNs, from shrinking margins and labor shortages to an onslaught of regulatory changes, including OPBBA, Medicaid work requirements, and ACA cuts. Mark is a healthcare technology marketing veteran with over 20 years in the industry. Mark and I discuss "the perfect storm" facing healthcare providers, and why traditional growth-focused messaging is no longer resonating with buyers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI Model Mania – Navigating the Healthtech Marketers Landscape with Adam Turinas On this lively episode, host Carol Flagg welcomes back Adam Turinas, founder of Health Launchpad and host of The Healthtech Marketing Show. Adam shares the story behind his AI Quick Takes segment—particularly the episode Model Mania: Navigating the New AI Landscape, which likens today's race among AI leaders to the 1990s browser wars. He explains how major players like OpenAI, Google, Anthropic, and Meta are locked in a fierce market “land grab” and discusses how marketers can navigate this expanding AI ecosystem and prepare for the next wave—the emerging “AI browser war” fueled by tools like ChatGPT Atlas and Perplexity Comet. The episode concludes with Adam talking about his firm's new initiative, the HLP BrAIn, a centralized repository of expertise and insights into healthcare buyers. Learn more about this initiative at: https://healthlaunchpad.com/the-hlp-brain-and-more/ To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

We've always believed that data drives better health, but even we were surprised by how powerful hormone data can be. Hormones influence everything from how we age to how our skin repairs itself, yet most people only test them once a year, if at all.In this episode, we sit down with Fady and Marina from Eli Health to explore how real-time hormone testing is changing the way we understand health optimization. Their saliva-based technology tracks cortisol and progesterone with over 90 percent lab-comparable accuracy, while their AI-powered app translates results into actionable lifestyle insights.We also unpack how cortisol rhythm shapes energy, mood, and skin health, why “cortisol face” is real, and how frequent hormone tracking can help prevent stress-related aging before it appears on the skin. Fady and Marina, founders of Eli Health, are redefining hormone care with a science-driven, ethically designed platform that keeps data and decisions in your hands.We Also Discuss:(01:07) How At-Home Hormone Testing Works(02:28) The Accuracy of Real-Time Cortisol and Progesterone Testing(04:20) Understanding Your Diurnal Cortisol Curve(07:13) AI-Powered Lifestyle Recommendations for Stress and Sleep(10:52) Using Hormone Insights to Personalize Your Routine(14:52) Cortisol, Skin Health, and “Cortisol Face”(19:22) The Rise of Frequent Hormone Tracking (“Fitbit for Hormones”)(24:11) Testosterone and Estradiol: The Next Frontier(37:38) Timing Skincare Treatments to Your Hormone Cycle(41:33) Ethics, Privacy, and Data Ownership in Health Tech(47:52) The Future of Hormone Tracking and LongevityFind more from Young Goose:Blue Peptide Spray: Cellular hydration meets antioxidant power → Blue Peptide SprayUse code PODCAST10 to get 10% off your first purchase, and if you're a returning customer use the code PODCAST5 to get 5% off at https://www.younggoose.com/ Instagram: @young_goose_skincareFind more from Eli HealthWebsite: eli.health Instagram: @myelihealth LinkedIn: Eli Health

In this episode of Medsider Radio, we sat down with Kaitlin Maier, co-founder and CEO of Reia. Reia has developed a self-managed pessary — a collapsible device that empowers women to treat pelvic organ prolapse comfortably and independently. A mechanical engineering graduate of Dartmouth, Kaitlin previously worked at Sherpa Technology Group, developing patent strategies for leading life science and technology firms. In this conversation, Kaitlin shares how she and her co-founders turned a student project into an FDA-cleared product using resource constraints as a design advantage. She explains how to turn FDA feedback into forward momentum, why running an NIH-funded randomized controlled trial (RCT) strengthened both credibility and confidence, and how non-dilutive funding can buy the time and control founders need to build on their own terms.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kaitlin Maier.

Send us a textPodcast Guesting is your best way to get visibility, credibility, and trust by sharing how you add value to your clients.In this episode of Business Growth Talks, hosted by Mark Hayward, listeners are treated to the remarkable journey of Marco Benitez, CEO and co-founder of Rook. Marco shares his path from a Taekwondo champion to spearheading a successful startup in the digital health space. Reflecting on his journey and challenges, Marco provides insights into the synergies between the discipline of martial arts and the resilience required in entrepreneurship. This episode is a masterclass on navigating startup challenges, building strategic partnerships, and the future of personalized healthcare.Marco delves into the inception of Rook, sharing the pivotal moment when he left a secure job in corporate pharma to pursue his dream of building a startup. The conversation covers the hurdles of innovating within healthcare tech, securing investment, and the critical role of discipline in entrepreneurship. With Rook, Marco emphasizes the transformation of wearable device data into actionable insights, underscoring the importance of preventing ailments before they arise. This insightful dialogue is a blend of personal anecdotes and practical advice for aspiring entrepreneurs eager to impact the health tech industry.Key Takeaways:Synergy of Disciplines: The discipline and perseverance from Marco's martial arts background significantly influenced his approach to entrepreneurship.Navigating Initial Challenges: Finding the first client and cultivating trust was crucial to Rook's early success and customer engagement.Strategic Partnerships: Alliances with entities like InterSystems accelerated Rook's influence in the health tech industry.Investor Relationships: Building authentic relationships and aligning investors with the company's mission were essential for Rook's funding success.Importance of Prenvention: Personalized data and proactive healthcare approaches can reshape health industries, offering better outcomes for individuals and organizations alike.SPONSORPodcast Guesting is your best way to get visbility, credibility and trust by sharing how you add value to your clients. If you want to set up a call, go to the websitewww.podcastintroduction.comResources:Rook Website: Try rook IOMarco Benitez on LinkedIn: Marco Antonio BenitezListeners are encouraged to dive into the full episode for more enriching conversations and stay tuned to discover more transformative journeys in the world of business, innovation, and entrepreneursSupport the showIf you want to watch the full video of this episode go to:https://www.youtube.com/@markhayward-BizGrowthTalksDo you want to be a guest on multiple podcasts as a service go to:www.podcastintroduction.comFind more details about the podcast and my coaching business on:www.businessgrowthtalks.comFind me onLinkedIn - https://www.linkedin.com/in/mark-hayw...Tik Tok - https://www.tiktok.com/@mjh169183YouTube Shorts - https://www.youtube.com/@markhayward-BizGrowthTalks/shorts

AI Browsers Are Coming for Your Buyer Journeys On this episode host Adam Turinas discusses the challenge of buyers control of the buying process, and they don't want to talk to vendors until they are good and ready. They do their research, talk to peers and analysts, do more research, and eventually, after several months, they will speak to a handful of vendors. And by then their mind is mainly made up. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Join host Lisa as she chats with Dr. Elizabeth Harris from Brain Health and Biofeedback about her journey from traditional medicine to holistic brain health. Discover links between dental health and wellness, treatments like plasmalogens and CO2 optimisation, and advanced tech such as CVAC and NeuroField. Perfect for those battling post-concussion syndrome, long COVID, POTS, Thyroid, Gut problems or chronic health issues, plus plans for New Zealand clinics! Connect with Dr. Harris: Website: Brain Health and Biofeedback For more episodes like this one with Dr. Harris's check out these episodes: Dr. Mark Gordon - Hormones, Brain Injuries, And Neuroinflammation Dr. Dale Bredesen - How to Prevent and Reverse Alzheimers & Neurodegeneration  

Our teacher today is Matteo Franceschetti, co-founder and CEO of Eight Sleep, whose Pod technology ranks among the top five products that have meaningfully improved my quality of life. This conversation launches our series on founders and investors revolutionizing human health, covering everything from diagnostics to longevity science to biotechnology. Matteo's story is fascinating—he's an unlikely health tech founder who grew up in Italy pursuing law with little scientific or medical background, yet he's combined the discipline of an elite multi-sport athlete with the resilience of a serial entrepreneur to build a category-defining company. We discuss the challenges of building a consumer hardware company and how his team raised capital from world-renowned investors while achieving cash flow positivity to control their destiny. Please enjoy class with our friend Matteo Franceschetti. For the full show notes, transcript, and links to mentioned content, check out the episode page⁠ here.⁠ —-- This episode is brought to you by⁠ ⁠Portrait Analytics⁠⁠ - your centralized resource for AI-powered idea generation, thesis monitoring, and personalized report building. Built by buy-side investors, for investment professionals. We work in the background, helping surface stock ideas and thesis signposts to help you monetize every insight. In short, we help you understand the story behind the stock chart, and get to "go, or no-go" 10x faster than before. Sign-up for a free trial today at⁠ ⁠portraitresearch.com⁠⁠ —-- Joys of Compounding is a property of Pine Grove Studios in collaboration with Colossus, LLC. For more episodes of Joys of Compounding, visit⁠ joincolossus.com/episodes⁠.  Editing and post-production work for this episode was provided by The Podcast Consultant (⁠https://thepodcastconsultant.com⁠). Follow us on Twitter: ⁠@Buhrman_Rick⁠  | ⁠@PaulBuser⁠ | ⁠@JoinColossus⁠ Show Notes (00:00:00) Welcome to The Joys of Compounding (00:00:57) Meet Mateo Franceschetti: The Sleep Maestro (00:01:48) Mateo's Journey: From Italy to Health Tech (00:02:45) The Science and Impact of Sleep (00:05:57) Personal Stories and Early Ventures (00:15:23) From Law to Entrepreneurship (00:27:54) The Birth of Eight Sleep (00:32:20) Thought Partners and Business Ventures (00:32:42) The Importance of Sleep: Insights from Experts (00:34:29) The Evolution of Sleep Awareness (00:35:22) Innovating Sleep Technology (00:36:37) Building Eight Sleep: Challenges and Vision (00:40:04) Understanding Sleep Stages and Optimization (00:45:01) Balancing Execution and Vision in Business (00:47:39) Fundraising Journey and Lessons Learned (00:52:20) The Role of AI in Eight Sleep's Future (01:00:09) Future Ambitions and Product Roadmap

In this episode of Medsider Radio, we sat down with Somer Baburek, CEO and co-founder of Hera Biotech. Hera is developing AI-driven tissue diagnostics for conditions that disproportionately affect women, including endometriosis and cervical cancer.Before launching Hera, Somer spent nearly a decade in venture capital, where she evaluated early-stage medtech startups and learned what separates the survivors from the rest.In this conversation, Somer explains how Hera designed global clinical pathways that balance cost and credibility, why boutique CROs can outperform big names, and how a pre-commercial startup completed three strategic acquisitions using equity and brand trust rather than cash.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Somer Baburek.

Our AI Story - Episode 100! On this episode host Adam Turinas discusses their milestone 100th episode of The HealthTech Marketing Show, He reflects on the journey to reach this point and share something they have never done before—opening up about what they have been building at Health Launchpad with AI. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Daniel Rudyak, co-founder of ReadyRx, joins us to talk about redefining the future of wellness, healthcare, and health tech innovation. With over $1 billion in business transactions and multiple high-growth startups under his belt, Daniel brings rare insight into how entrepreneurs can scale purpose-driven companies without losing sight of their mission.Inspired by his father's battle with chronic illness, Daniel shares how personal experience shaped ReadyRx's vision for proactive care and better patient access. In this episode, we unpack the intersection of business, mission, and technology—plus Daniel's honest take on what it really takes to build and grow in the health tech space today.

The episode explores how Warner Thomas is transforming Sutter Health into a digitally-enabled, ambulatory-focused health system that can navigate major industry headwinds through growth rather than contraction. Thomas discusses Sutter's aggressive expansion of its physician network and ambulatory footprint, the system's push to dramatically improve consumer experience through technologies like online booking and ambient AI documentation, and their strategic pivot toward value-based care models as Medicare payment pressures intensify. Throughout the conversation, he emphasizes that successful health systems must embrace AI and digital tools not as futuristic concepts but as immediate operational necessities, while maintaining focus on integrated care delivery that keeps patients at the center—a philosophy shaped by his experience building integrated systems at Ochsner and now applied to reimagining Sutter's historically hospital-centric culture into one that blends physical and digital care delivery across the full continuum. (0:00) Intro(1:01) Overview of Sutter Health(1:56) Comparing Sutter Health and Ochsner(4:08) Key Focus Areas for Sutter Health(6:49) Consumer Experience and Technology Integration(10:56) The Role of AI in Healthcare(18:03) Advice for Startups in Health Tech(21:19) Navigating Financial Challenges in Healthcare(24:23) Healthcare Policy and Advocacy(25:59) Competition and Differentiation in Healthcare(29:58) Value-Based Care and Medicare(34:03) Quickfire Out-Of-Pocket: https://www.outofpocket.health/

Episode 67 - Dr Natalie Banner is Chief Ethics and Engagement Officer at Genomics England, a UK Government-owned organisation advancing genomic research, medicine and the use of genomics in healthcare. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Does it feel like we packed in a decade of progress this year in digital health? We think so. Today, Halle and Steve break down the biggest digital health stories of the moment, from funding trends to AI rivalries and new rules shaping the future of care.We cover:

Over 3 million clinicians around the world depend on UpToDate to guide patient care, and now the gold standard in clinical decision support is integrating generative AI. But in a world where AI models often hallucinate, how do you build something that doctors can actually trust?In this episode, Halle talks with Dr. Holly Urban, VP of Business Development and Strategy at Wolters Kluwer Health, about UpToDate Expert AI, a new tool trained exclusively on UpToDate's physician-authored content — not the open internet — and what it means for the future of medicine.We cover:

AI accelerates drug discovery while steroids turn teens into aggressive strangers. Dr. Michael Israetel explores our pharmaceutical crossroads here!Full show notes and resources can be found here: jordanharbinger.com/1209What We Discuss with Michael Israetel:GLP-1 drugs like Tirzepatide offer massive health benefits beyond weight loss — reducing inflammation, improving brain health, and decreasing addiction behaviors, even for people already in good shape.Steroids don't just amplify personality — they specifically amplify masculine traits like aggression and reduce empathy. Starting young can permanently rewire your brain's emotional and social processing.AI is about to revolutionize medicine by testing millions of drug candidates virtually, creating treatments 10x more effective with 10x fewer side effects. We're entering the pharmaceutical iPhone moment.The "only take drugs when sick" mindset worked in the 20th century, but is becoming dangerously outdated — like refusing elevators because you prefer human operators.When your diet plateaus, take a week-long break eating at maintenance. Your stress hormones will drop, body water will flush out, and you'll often look leaner than before.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Saily: 15% off: saily.com/jordanharbinger, code JORDANHARBINGERDripDrop: 20% off: DripDrop.com, code JORDANLinkedIn Jobs: Post your job for free: linkedin.com/jordanQuince: Free shipping & 365-day returns: quince.com/jordanBetterHelp: 10% off first month: betterhelp.com/jordanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.